644 Results for "

ATPases

" in MedChemExpress (MCE) Product Catalog:
Products (644)

644 Results for "ATPases" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-15718A
CAS No.: 374559-48-5
Purity:  99.28%
Synonyms: PST2744 hydrochloride
Research Areas:  

Cardiovascular Disease

Istaroxime hydrochloride is a Na +/K +-ATPase inhibitor (IC50=0.11 μM) and a sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA 2) activator.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-13719
CAS No.: 465-16-7
Purity:  99.91%
Synonyms: PBI-05204
Category:  

Steroids

Target:  

Na+/K+ ATPase

Oleandrin (PBI-05204) inhibits the Na +, K +-ATPase activity with an IC50 of 620 nM.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-N2033
CAS No.: 18942-26-2
Chebulinic acid is a potent natural inhibitor of M. tuberculosis DNA gyrase, also can inhibit SMAD-3 phosphorylation, inhibit H+ K+-ATPase activity.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-128892
CAS No.: 1808714-73-9
Purity:  99.42%
Target:  

Autophagy

Research Areas:  

Neurological Disease

EN6 is a small-molecule in vivo autophagy activator that covalently targets cysteine 277 in the ATP6V1A subunit of the lysosomal v-ATPase. EN6-mediated modification of ATP6V1A uncouples v-ATPase from Rag, leading to inhibition of mTORC1 signalling, increased lysosomal acidification, and activation of autophagy. EN6 also scavenges TDP-43 aggregates (causative agents of frontotemporal dementia) in a lysosome-dependent manner .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-147124
CAS No.: 2642218-43-5
Purity:  98.21%
Target:  

IFNAR

Research Areas:  

Infection Cancer

RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM using the NADH-coupled ATPase assay. RIG012 inhibits IFN-β and ISG hRsad2 expression .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15295
CAS No.: 881681-01-2
Purity:  101.1%
Synonyms: TAK-438
Target:  

Proton Pump

Research Areas:  

Infection Inflammation/Immunology

Vonoprazan Fumarate (TAK-438), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan Fumarate inhibits H +,K +-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan Fumarate is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-100007A
CAS No.: 1957202-44-6
Synonyms: TAK-438 hydrochloride
Target:  

Proton Pump Bacterial

Research Areas:  

Infection Endocrinology Cancer

Vonoprazan hydrochloride, a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan hydrochloride inhibits H +,K +-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan hydrochloride is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease. Vonoprazan hydrochloride can be used for eradication of Helicobacter pylori .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-100007
CAS No.: 881681-00-1
Purity:  99.40%
Synonyms: TAK-438 free base
Target:  

Proton Pump Bacterial

Research Areas:  

Infection

Vonoprazan (TAK-438 free base), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan inhibits H +,K +-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease. Vonoprazan can be used for eradication of Helicobacter pylori .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-19795
CAS No.: 1346527-98-7
Target:  

p97

Research Areas:  

Cancer

ML240 is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-119254
CAS No.: 2099142-76-2
Purity:  98.33%
Research Areas:  

Metabolic Disease

BAY-850, a chemical probe, is a potent and isoform selective ATPase family AAA domain-containing protein 2 (ATAD2) inhibitor, with an IC50 of 166 nM .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-101298
CAS No.: 57046-73-8
Purity:  99.87%
Target:  

Kinesin

Research Areas:  

Neurological Disease

Paprotrain is a cell-permeable inhibitor of the kinesin MKLP-2, inhibits the ATPase activity of MKLP-2 with an IC50 of 1.35 μM and a Ki of 3.36 μM and shows a moderate inhibition activity on DYRK1A with an IC50 of 5.5 μM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-103319
CAS No.: 57265-65-3
Purity:  99.94%
Synonyms: R 24571
Target:  

Autophagy Calmodulin

Research Areas:  

Neurological Disease Cancer

Calmidazolium chloride (R 24571) is a calmodulin antagonist, antagonizing CaM-dependent phosphodiesterase and calmodulin-induced activation of erythrocyte Ca2+-transporting ATPase with IC50s of 0.15 and 0.35 μM, respectively . Also in anti-cancer research . Calmidazolium binds to calmodulin with a Kd of 3 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-100560
CAS No.: 21293-29-8
Purity:  99.64%
Synonyms: (S)​-​(+)​-​Abscisic acid; ABA
Abscisic acid ((S)-(+)-Abscisic acid), an orally active phytohormone in fruits and vegetables, is an endogenously produced mammalian hormone. Abscisic acid is a growth inhibitor and can regulate many aspects of plant growth and development. Abscisic acid inhibits proton pump (H +-ATPase) and leads to the plasma membrane depolarization in a Ca 2+-dependent manner. Abscisic acid, a LANCL2 natural ligand, is a potent insulin-sensitizing compound and has the potential for pre-diabetes, type 2 diabetes and metabolic syndrome .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-110185
CAS No.: 203115-63-3
Purity:  99.18%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

NSC 617145 is a selective werner syndrome helicase (WRN) helicase inhibitor with an IC50 value of 230 nM. NSC 617145 inhibits WRN ATPase, and induces double-strand breaks (DSB) and chromosomal abnormalities. NSC 617145 shows selective for WRN over BLM, FANCJ, ChlR1, RecQ, and UvrD helicases .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N2070
CAS No.: 25161-41-5
Acevaltrate inhibits the Na +/K +-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-135474
CAS No.: 304481-60-5
Purity:  99.67%
Research Areas:  

Others

KM91104 is a cell-permeable V-ATPase a3-b2 inhibitor (IC50 = 2.3 µM). KM91104 reduces the metabolic activity, cell proliferation capacity and V-ATPase subunit protein expression levels of primary human hepatic stellate cells, increases intracellular ATP levels and decreases cytoplasmic pH. KM91104 reduces TLR4 expression on the surface of oligodendrocyte precursor cells, blocks the ENV-TLR4 interaction, and reverses oligodendrocyte myelination defects induced by ENV protein .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-110273
CAS No.: 862974-25-2
Purity:  99.58%
Research Areas:  

Cardiovascular Disease

N106 is a first-in-class sarcoplasmic reticulum calcium ATPase (SERCA2a) SUMOylation activator. N106 directly activates the SUMO-activating enzyme, E1 ligase. N106 can be used for heart failure research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-138364
CAS No.: 423145-35-1
Purity:  98.01%
Target:  

HSP Apoptosis

Research Areas:  

Cancer

YUM70 is a potent and selective inhibitor of glucose-regulated protein 78 (GRP78), with an IC50 of 1.5 μM for inhibiting GRP78 ATPase activity of the full-length protein. YUM70 induces endoplasmic reticulum (ER) stress-mediated apoptosis in pancreatic cancer. YUM70 also has in vivo efficacy in a pancreatic cancer xenograft model .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-17507
CAS No.: 102625-70-7
Synonyms: BY1023; SKF96022
Pantoprazole (BY10232) is an orally active and potent proton pump inhibitor (PPI) . Pantoprazole, a substituted benzimidazole, is a potent H +/K +-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole significantly increased tumor growth delay combined with Doxorubicin (HY-15142) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-17507A
CAS No.: 138786-67-1
Synonyms: BY1023 sodium; SKF96022 sodium
Pantoprazole sodium (BY10232 sodium) is an orally active and potent proton pump inhibitor (PPI) . Pantoprazole sodium, a substituted benzimidazole, is a potent H +/K +-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole sodium improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole sodium significantly increased tumor growth delay combined with Doxorubicin (HY-15142) .
loading...
    loading...